No Data
No Data
Appili Therapeutics – Press Release Correction
Express News | Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Appili Therapeutics Brief: Says Definitive Agreement With Aditxt, If Approved by Appili Shareholders, "Provides Significant Premium to Shareholders and Resources to Advance Key Programs"
Appili Therapeutics Brief: Notes U.S. Food and Drug Administration Meeting Request Submitted to Discuss ATI-1801 Registration Strategy
Express News | Aditxt Inc - Transaction Is Conditional Upon Aditxt Raising at Least US$20 Mln in Financing Before Closing
No Data